BRCA2

BRCA2

Target · Tumour suppressor

BRCA2 BRCA2 DNA repair associated · Breast cancer type 2 susceptibility protein

BRCA2 (BRCA2 DNA repair associated, also known as FANCD1, FAD1, BRCC2 and XRCC11) is a tumour suppressor that maintains genome stability by repairing damaged DNA through homologous recombination. It loads the RAD51 recombinase onto single-stranded DNA at double-strand breaks. Browse Assay Genie's current range of BRCA2 research reagents below, or read on for the biology behind the target.

Nuclear and chromosomalHomologous recombination mediatorLinked to multiple cancers
3418 aa
Protein length
~384 kDa
Molecular weight
13q13.1
Gene locus
FA group
Gene group
Target information

What is BRCA2 (BRCA2 DNA repair associated)?

BRCA2 repairs DNA double-strand breaks by homologous recombination (HR). It binds RAD51 and mediates its loading onto single-stranded DNA (ssDNA), which promotes RAD51-catalysed DNA strand exchange. BRCA2 nucleates and stabilises RAD51 on ssDNA directly, and delivers it to ssDNA-double-stranded DNA junctions by sliding along the dsDNA backbone. This targeting promotes removal of replication protein-A (RPA) from ssDNA and stabilises RAD51-ssDNA filaments by blocking ATP hydrolysis. BRCA2 also inactivates the FIGNL1-FIRRM complex, protecting RAD51 filaments from premature disassembly.

Beyond double-strand break repair, BRCA2 protects DNA replication forks and, together with PALB2, is involved in POLH localisation at collapsed replication forks. It is required to prevent R-loop-associated DNA damage, and silencing of BRCA2 promotes R-loop accumulation at actively transcribed genes, independently of its role in HR. It promotes RAD51 loading at telomeric regions, supporting telomere replication and capping. In meiosis it recruits RAD51 and DMC1 to meiotic break sites, enabling chromosome pairing and crossing over. With NPM1, it may regulate centrosome duplication, and it also contributes to cytoplasmic division.

The BRCA2 gene encodes a large protein with an N-terminal DNA-binding domain, sites for interaction with PALB2 and EMSY, and a RAD51-binding region built from multiple BRC repeats. It also contains an alpha helix domain, oligonucleotide-binding folds, a tower-like domain, a nuclear localisation signal and a cyclin-dependent kinase phosphorylation site. The C-terminus binds both ssDNA and dsDNA. UniProt places the protein on chromosomes, at telomeres, in the nucleus and at the centrosome. Previously named Fanconi anaemia, complementation group D1, it belongs to the FA complementation groups. Mutations or reduced expression are implicated in breast, ovarian, pancreatic, prostate and other cancers.

DNA damage repair

BRCA2 mediates RAD51 loading onto ssDNA during homologous recombination, making it central to studies of double-strand break repair.

Cancer biology

Mutations or decreased expression of BRCA2 are implicated in breast, ovarian, pancreatic, prostate and other cancers.

Replication fork protection

BRCA2 helps protect replication forks and limits R-loop-associated damage, informing research on genomic instability during replication and transcription.

Meiosis and telomere biology

BRCA2 recruits RAD51 and DMC1 in meiosis and loads RAD51 at telomeres, supporting chromosome pairing, crossing over and telomere capping.

Background

BRCA2 frequently asked questions

What does BRCA2 do?

BRCA2 is a tumour suppressor that maintains genome stability, mainly through homologous recombination. It binds RAD51 and loads it onto single-stranded DNA at double-strand breaks, stabilising RAD51 filaments. It also protects replication forks, limits R-loop-associated damage and may help regulate centrosome duplication with NPM1.

What other names is BRCA2 known by?

BRCA2 is also called FANCD1, FAD, FAD1, FACD, FANCD, BRCC2 and XRCC11. Previous names include breast cancer 2, early onset, and Fanconi anaemia, complementation group D1. UniProt lists the protein as breast cancer type 2 susceptibility protein.

Is BRCA2 conserved across species and linked to disease?

Mouse and rat both have a Brca2 ortholog. In humans, mutations in the BRCA2 gene or decreased expression have been implicated in multiple tumour types, including breast, ovarian, pancreatic and prostate cancers. Check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other DNA repair proteins, homologous recombination factors and tumour suppressors with products at Assay Genie.

Gene and protein annotations from HGNC, NCBI Gene and UniProt P51587; product specifications from Assay Genie datasheets.

BRCA2 Product listing